Coronavirus Turmoil Scuppers $3 Billion Europe Buyout Deal

(Bloomberg) -- Curium Pharma, the private equity-owned medical supplies firm, is deferring a sale of the company due to the coronavirus-induced market volatility.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.